Riluzole | Interleukin Related interleukin-related.com

Product Name :
Riluzole

Search keywords :
Riluzole

drugId :
null

Target Vo:
Sodium channel alpha subunit

Target Vo Short Name :
SCNA

Moa_Name:
Sodium channel alpha subunit modulators

First Approval Country :
United States

First Approval Date Filter:
1995

Origin Company_Name :
Sanofi

Active Company_Name :
Aventis Pharma (Nenagh) Ltd

Active Indication_Name:
Amyotrophic Lateral Sclerosis

In Active Indication_Name:
Developmental Disabilities

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKA R2 Antibody
TCF7L2/TCF4 Antibody
Adiponectin receptor protein 1 Antibody: Adiponectin receptor protein 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Adiponectin receptor protein 1. It can be used for ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts